5 years ago
Young blood cocktail stops Alzheimer's decline, early clinical trial reports
Alkahest, a California-based start-up, has just revealed some compelling early results from an ongoing Phase 2 trial into the efficacy of its novel formulation of plasma proteins derived from young blood, developed to slow, or even stop, the cognitive decline associated with Alzheimer’s disease.
Continue Reading
https://newatlas.com
Join the Discussion